We are live on ! Find out more
DNTH icon

Dianthus Therapeutics

94 hedge funds and large institutions have $211M invested in Dianthus Therapeutics in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 20

1% more funds holding

Funds holding: 9394 (+1)

1.03% more ownership

Funds ownership: 4.04%5.07% (+1%)

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

23% less capital invested

Capital invested by funds: $276M → $211M (-$64.5M)

94% less call options, than puts

Call options by funds: $3K | Put options by funds: $52K

Holders
94
Holders Change
+1
Holders Change %
+1.08%
% of All Funds
1.45%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
17
Increased
26
Reduced
20
Closed
16
Calls
$3K
Puts
$52K
Net Calls
-$49K
Net Calls Change
-$135K
Name Holding Trade Value Shares
Change
Change in
Stake
PPA
101
Parametric Portfolio Associates
Washington
-$111K -950 Closed
AG
102
Algert Global
California
-$109K -939 Closed
SG Americas Securities
103
SG Americas Securities
New York
-$107K -915 Closed
PCM
104
Penserra Capital Management
California
-$9K -83 Closed
S
105
SignatureFD
Georgia
-$1K -5 Closed
QCG
106
Quadrant Capital Group
Ohio
+$402 +4 New